SMALL LABEL / REFERENCE DESK

Our evidence line

Manufacturer statements,retailer prices,primary FDA/AAD/AAP context and user arithmetic remain separate. Aveeno maker newborn wording and Target1YearUp field are preserved as unresolved. Mustela from-birth wording is not universal newborn clearance. Drug Facts actives/purpose are distinct from cosmetic-style ingredient lists. Mass and volume are not converted without density. No dose,frequency,eczema treatment,skin test or invented caregiver review is provided. Independent pediatric clinical,editorial and legal-scope review remains pending.

Updated November4,2026.